
Episode 34: General Atlantic's Brett Zbar
BioVenture VoiCes with Chris Garabedian
00:00
Therapeutic priorities and modality views
He explains selective interest in gene/cell therapy and focus on cardiometabolic, oncology, neuroscience.
Play episode from 49:00
Transcript


